Reuters: Regulatory News: Mylan, Pfizer settle patent suit on generic Detrol LA

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Mylan, Pfizer settle patent suit on generic Detrol LA Sep 7th 2012, 12:04 Sept 7 | Fri Sep 7, 2012 8:04am EDT Sept 7 (Reuters) - Mylan Inc said it settled with Pfizer Inc a lawsuit that accused it of infringing patents on overactive bladder drug Detrol LA. Mylan can start selling its generic versions of Pfizer's drug from Jan. 1, 2014, or earlier under some limited circumstances, but not after March 1, 2014, if the U.S. Food and Drug Administration approves. Terms of the settlement are subject to review by the Federal Trade Commission and the U.S. Department of Justice, and other details are confidential, Mylan said. The settlement with Mylan comes days after Pfizer resolved a similar dispute with Impax Laboratories Inc late last month.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions